MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program
Go back to MacroGenics Announces Achievement of $15 Million Milestone Related to Gilead’s Nomination of a Bispecific Research Program| Gilead Sciences (NASDAQ: GILD) | Delayed: 151.00 -0.22 (0.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $151.22 | 52 Week High | $108.63 | |||
| Open | $149.23 | 52 Week Low | $71.39 | |||
| Day High | $151.19 | P/E | 83.43 | |||
| Day Low | $149.23 | EPS | $1.81 | |||
| Volume | 6,181,813 | |||||
| MACROGENICS (NASDAQ: MGNX) | Delayed: 4.40 +0.15 (3.53%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.25 | 52 Week High | $36.11 | |||
| Open | $4.20 | 52 Week Low | $14.84 | |||
| Day High | $4.49 | P/E | 11.28 | |||
| Day Low | $4.18 | EPS | $0.39 | |||
| Volume | 442,786 | |||||

